MCID: OVR018
MIFTS: 10

Ovarian Clear Cell Malignant Adenofibroma

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Ovarian Clear Cell Malignant Adenofibroma

MalaCards integrated aliases for Ovarian Clear Cell Malignant Adenofibroma:

Name: Ovarian Clear Cell Malignant Adenofibroma 12
Ovarian Clear Cell Adenocarcinofibroma 12 69

Classifications:



External Ids:

Disease Ontology 12 DOID:6554
NCIt 47 C40079

Summaries for Ovarian Clear Cell Malignant Adenofibroma

MalaCards based summary : Ovarian Clear Cell Malignant Adenofibroma, is also known as ovarian clear cell adenocarcinofibroma. The drugs Bevacizumab and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include endothelial.

Related Diseases for Ovarian Clear Cell Malignant Adenofibroma

Diseases in the Ovarian Clear Cell Adenofibroma family:

Ovarian Clear Cell Malignant Adenofibroma

Symptoms & Phenotypes for Ovarian Clear Cell Malignant Adenofibroma

Drugs & Therapeutics for Ovarian Clear Cell Malignant Adenofibroma

Drugs for Ovarian Clear Cell Malignant Adenofibroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bevacizumab Approved, Investigational Phase 3 216974-75-3
2
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
3
Gemcitabine Approved Phase 3 95058-81-4 60750
4
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
5
Docetaxel Approved May 1996, Investigational Phase 3 114977-28-5 148124 9877265
6 Albumin-Bound Paclitaxel Phase 3
7 Angiogenesis Inhibitors Phase 3
8 Angiogenesis Modulating Agents Phase 3
9 Antibodies Phase 3
10 Antibodies, Monoclonal Phase 3
11 Anti-Infective Agents Phase 3
12 Antimetabolites Phase 3
13 Antimetabolites, Antineoplastic Phase 3
14 Antimitotic Agents Phase 3
15 Antineoplastic Agents, Phytogenic Phase 3
16 Antiviral Agents Phase 3
17 Endothelial Growth Factors Phase 3
18 Immunoglobulins Phase 3
19 Immunosuppressive Agents Phase 3
20 Mitogens Phase 3

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Active, not recruiting NCT00565851 Phase 3 Carboplatin;Docetaxel;Gemcitabine Hydrochloride;Paclitaxel
2 Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Active, not recruiting NCT01167712 Phase 3 Carboplatin;Paclitaxel

Search NIH Clinical Center for Ovarian Clear Cell Malignant Adenofibroma

Genetic Tests for Ovarian Clear Cell Malignant Adenofibroma

Anatomical Context for Ovarian Clear Cell Malignant Adenofibroma

MalaCards organs/tissues related to Ovarian Clear Cell Malignant Adenofibroma:

39
Endothelial

Publications for Ovarian Clear Cell Malignant Adenofibroma

Variations for Ovarian Clear Cell Malignant Adenofibroma

Expression for Ovarian Clear Cell Malignant Adenofibroma

Search GEO for disease gene expression data for Ovarian Clear Cell Malignant Adenofibroma.

Pathways for Ovarian Clear Cell Malignant Adenofibroma

GO Terms for Ovarian Clear Cell Malignant Adenofibroma

Sources for Ovarian Clear Cell Malignant Adenofibroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....